Table 1 Chi square analysis in the prognostic evaluation of biomarkers
From: Construction of a lipid metabolism-related and immune-associated prognostic score for gastric cancer
LMAGs expression | Alive | Dead | P value |
|---|---|---|---|
N | 227 (61%) | 144 (39%) | |
ADH4 | 0.37 | ||
High | 109 (59%) | 76 (41%) | |
Low | 118 (63%) | 68 (37%) | |
AKR1B1 | 0.002 | ||
High | 99 (54%) | 86 (46%) | |
Low | 128 (69%) | 58 (31%) | |
CYP4A11 | 0.97 | ||
High | 113 (61%) | 72 (39%) | |
Low | 114 (61%) | 72 (39%) | |
NEU2 | 0.1 | ||
High | 80 (56%) | 63 (44%) | |
Low | 147 (64%) | 81 (36%) | |
SMPD3 | 0.15 | ||
High | 120 (65%) | 65 (35%) | |
Low | 107 (58%) | 79 (42%) | |
ST6GALNAC3 | 0.009 | ||
High | 101 (55%) | 84 (45%) | |
Low | 126 (68%) | 60 (32%) |